These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20179939)

  • 21. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterization/pre-qualification study.
    ;
    Clin Transl Radiat Oncol; 2023 Sep; 42():100666. PubMed ID: 37583808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
    Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
    Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging in locally advanced rectal cancer: quantitative evaluation of the complete response to neoadjuvant therapy.
    Tarallo N; Angeretti MG; Bracchi E; Xhepa G; Molinelli V; Tagliaferri C; Antognoni P; Novario R; Sessa F; Fugazzola C
    Pol J Radiol; 2018; 83():e600-e609. PubMed ID: 30800199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT.
    Matoba M; Tuji H; Shimode Y; Kondo T; Oota K; Tonami H
    J Radiat Res; 2015 May; 56(3):553-60. PubMed ID: 25829531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy.
    Hatakenaka M; Nakamura K; Yabuuchi H; Shioyama Y; Matsuo Y; Ohnishi K; Sunami S; Kamitani T; Setoguchi T; Yoshiura T; Nakashima T; Nishikawa K; Honda H
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):339-45. PubMed ID: 20832179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
    Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
    Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings.
    Vandecaveye V; De Keyzer F; Nuyts S; Deraedt K; Dirix P; Hamaekers P; Vander Poorten V; Delaere P; Hermans R
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):960-71. PubMed ID: 17141979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients.
    Chen Y; Xie T; Ye Z; Wang F; Long D; Jiang M; Fang J; Lin Q; Li K; Wang Z; Fu Z
    Radiat Oncol; 2019 Nov; 14(1):192. PubMed ID: 31684999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imaging.
    Marzi S; Piludu F; Sanguineti G; Marucci L; Farneti A; Terrenato I; Pellini R; Benevolo M; Covello R; Vidiri A
    Eur J Radiol; 2017 Jul; 92():93-102. PubMed ID: 28624026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiparametric functional MRI and
    Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA
    Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.
    King AD; Chow KK; Yu KH; Mo FK; Yeung DK; Yuan J; Bhatia KS; Vlantis AC; Ahuja AT
    Radiology; 2013 Feb; 266(2):531-8. PubMed ID: 23151830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of conventional and diffusion weighted MRI in predicting treatment response after low dose radiation and chemotherapy in locally advanced carcinoma cervix.
    Das S; Chandramohan A; Reddy JK; Mukhopadhyay S; Kumar RM; Isiah R; John S; Oommen R; Jeyaseelan V
    Radiother Oncol; 2015 Nov; 117(2):288-93. PubMed ID: 26475249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.
    Dirix P; Vandecaveye V; De Keyzer F; Stroobants S; Hermans R; Nuyts S
    J Nucl Med; 2009 Jul; 50(7):1020-7. PubMed ID: 19525447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma.
    Vandecaveye V; De Keyzer F; Dirix P; Lambrecht M; Nuyts S; Hermans R
    Neuroradiology; 2010 Sep; 52(9):773-84. PubMed ID: 20631998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.
    Srinivasan A; Chenevert TL; Dwamena BA; Eisbruch A; Watcharotone K; Myles JD; Mukherji SK
    J Comput Assist Tomogr; 2012; 36(1):131-7. PubMed ID: 22261783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
    Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R
    Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.